Y. Kaneda

发表

Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma

K. Nishioka, M. Wu, T. Satoh, 2004, Gene Therapy.

Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart.

K. Matsumoto, T. Nakamura, Y. Kaneda, 1999, The Annals of thoracic surgery.

Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model

M. Aoki, T. Ogihara, Y. Kaneda, 2005, Gene Therapy.

A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFkappaB binding site: evidence for a role of NFkappaB in ischemia-reperfusion injury.

Y. Kaneda, R. Morishita, H. Matsuda, 1997, Circulation.

Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy.

Y. Kaneda, R. Morishita, T. Ochi, 1999, Arthritis and rheumatism.

Prolonged transgene expression in glomeruli using an EBV replicon vector system combined with HVJ liposomes.

Y. Kaneda, M. Hori, E. Imai, 2001, Kidney international.

Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts

Y. Kaneda, R. Morishita, M. Isobe, 2000, Gene Therapy.

Therapeutic angiogenesis induced by hepatocyte growth factor: potential gene therapy for ischemic diseases.

Y. Taniyama, M. Aoki, T. Ogihara, 2000, Journal of atherosclerosis and thrombosis.

Nuclear factor-κB decoy attenuates neuronal damage after global brain ischemia: A future strategy for brain protection during circulatory arrest

R. Morishita, M. Nishimura, T. Ueno, 2001 .

Gene therapy for preventing neuronal death using hepatocyte growth factor: in vivo gene transfer of HGF to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neurons

A. Hara, K. Matsumoto, T. Ogihara, 2001, Gene Therapy.

Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery.

T. Ogihara, Y. Kaneda, R. Morishita, 1994, Gene.

Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium cells.

Y. Tano, M. Kamei, N. Tomita, 2000, American journal of ophthalmology.

The improved efficient method for introducing macromolecules into cells using HVJ (Sendai virus) liposomes with gangliosides.

M. Ishiura, T. Uchida, Y. Okada, 1987, Experimental cell research.

Characterization of in vivo gene transfer into the arterial wall mediated by the Sendai virus (hemagglutinating virus of Japan) liposomes: an effective tool for the in vivo study of arterial diseases.

R. Morishita, K. Nakagawa, Y. Yonemitsu, 1996, Laboratory investigation; a journal of technical methods and pathology.

Overexpression of prostacyclin synthase inhibits growth of vascular smooth muscle cells.

T. Ogihara, Y. Kaneda, R. Morishita, 1995, Biochemical and biophysical research communications.

Inhibition of neointimal hyperplasia after balloon injury by cis-element ‘decoy’ of early growth response gene-1 in hypercholesterolemic rabbits

M. Aoki, Y. Kaneda, R. Morishita, 2004, Gene Therapy.

Prevention and regression of atopic dermatitis by ointment containing NF-kB decoy oligodeoxynucleotides in NC/Nga atopic mouse model

M. Aoki, T. Ogihara, Y. Kaneda, 2002, Gene Therapy.

Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element ‘decoy’ of nuclear factor-kB binding site as a novel molecular strategy

T. Ogihara, Y. Kaneda, R. Morishita, 2001, Gene Therapy.

Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells

Y. Kaneda, R. Morishita, J. Park, 2001, Diabetologia.

Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model

M. Aoki, K. Matsumoto, T. Nakamura, 2001, Diabetologia.

In vivo gene transfection of human endothelial cell nitric oxide synthase in cardiomyocytes causes apoptosis-like cell death. Identification using Sendai virus-coated liposomes.

Y. Kaneda, W. Shin, A. Sakamoto, 1997, Circulation.

Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells.

M. Aoki, K. Matsumoto, T. Nakamura, 1996, Biochemical and biophysical research communications.

Highly efficient eradication of intracranial glioblastoma using Eg5 siRNA combined with HVJ envelope

Y. Kaneda, A. Matsumura, Tetsuya Yamamoto, 2009, Gene Therapy.

Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function.

K. Matsumoto, T. Nakamura, Y. Kaneda, 2001, The Journal of clinical investigation.

Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell growth.

M. Aoki, T. Ogihara, Y. Kaneda, 1999, Hypertension.

A novel strategy of decoy transfection against nuclear factor-kappaB in myocardial preservation.

Y. Kaneda, H. Matsuda, H. Ichikawa, 2001, The Annals of thoracic surgery.

In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis.

T. Ogihara, Y. Kaneda, R. Morishita, 2000, Journal of the American Society of Nephrology : JASN.

Inhibition of Experimental Abdominal Aortic Aneurysm in the Rat by Use of Decoy Oligodeoxynucleotides Suppressing Activity of Nuclear Factor B and ets Transcription Factors

R. Morishita, K. Kataoka, Motokuni Aoki, 2003 .

Role of AP-1 complex in angiotensin II-mediated transforming growth factor-beta expression and growth of smooth muscle cells: using decoy approach against AP-1 binding site.

T. Ogihara, Y. Kaneda, R. Morishita, 1998, Biochemical and biophysical research communications.

Transfection of NFkappaB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts.

R. Morishita, N. Tomita, H. Koike, 2003, Gene therapy.